General Practitioners

• Primary Care
  Please bring your insurance information, referral forms, and identification cards to our office on your first visit. If your insurance requires a referral from your primary care physician, it must be in place in order for you to be seen.

Ophthalmologists

• Ophthalmology
  Scott D. Walter, M.D., M.Sc., FASRS joins Retina Consultants after completing a 2-year combined fellowship in Vitreoretinal Surgery and Medical Retina at the Duke University Eye Center, the top-rated retina program in the U.S. He is also the only Ocular Oncology specialist in Connecticut, having completed a fellowship in Ocular Oncology in addition to his Ophthalmology residency at the world-renowned Bascom Palmer Eye Institute. Bascom Palmer has consistently been ranked the #1 Eye Hospital by U.S. News & World Report.
• Macular Degeneration
  Intravitreal injections are currently the most commonly performed medical procedure in the United States, with retina specialists performing over 4 million injections annually for age-related macular degeneration and diabetic macular edema. Dr. Carl Awh (Tennessee Retina; Nashville, TN) presented preliminary results from the phase 2 LADDER Study, which evaluated the safety and efficacy of a new port delivery system for the administration of an intravitreal drug (Lucentis by Genentech Inc.) in patients with wet macular degeneration. Subjects in three experimental arms of the study received different drug concentrations, demonstrating an incremental dose response. Subjects receiving the highest dose (100mg/mL) had visual acuity and anatomic outcomes similar to patients receiving monthly intravitreal injections.
• Laser Eye Surgery
  Dr. Stanislao Rizzo (Eye Surgery Clinic in Pisa, Italy) presented a new technique for closure of macular holes, using a human amniotic membrane graft introduced into the subretinal space. The results of his initial case series were very encouraging with excellent anatomic outcomes and the majority of patients with refractory macular holes demonstrating significant visual acuity gains. Many in the audience were wowed by Dr. Rizzo’s technique, but it remains to be seen whether these outcomes can be replicated at other centers.
• Cataracts
  The FDA recently approved a new hypersonic vitrectomy system (Vitesse; Bausch+Lomb, Inc., Bridgewater, NJ) with a novel mechanism of action and a theoretical “cut rate” approaching 1.7 million cuts-per-minute. The technology is similar to phacoemulsification (the surgical technique for cataract removal) although the probe size, geometry, and stroke length have been optimized for vitreous removal.

Internists

• Internal Medicine
  Dr. Judson completed his internship in internal medicine at Lenox Hill Hospital in New York City and his residency in ophthalmology at Manhattan Eye, Ear & Throat Hospital, where he also served as chief resident, completed a Vitreo-Retinal Fellowship, and served as an instructor in retinal diseases.

Endocrinologist

• Diabetic Retinopathy
  As one of our patients, you will benefit from our expertise as well as the very latest techniques and technology. Our team of retinal specialists is especially qualified to diagnose and treat diseases of the retina and vitreous, diabetic retinopathy, ocular trauma, macular degeneration, and other systemic diseases and conditions that affect the eye.

Radiologist

• Ultrasound

Surgeons

• Orthopedics

Dermatologists

• Skin Cancer
  Two things patients fear most are cancer and blindness. Unfortunately, patients diagnosed with uveal melanoma (a rare form of eye cancer) may have to face both. While local cure rates with current therapies approach 90–95% for patients, vision loss often occurs later as a result of radiation damage to the optic nerve and macula.